Lehekülje analüüsi värskendamise kuupäev:2026/04/01 11:16:39
Viimase whoisi värskenduse kuupäev:2026/02/16 13:54:30
Domeeni olek
Registreeritud
Makstud kuni
06.11.2027
Saadaval alates
06.12.2027
×
synapse.patsnap.com Veebisaidi ekraanipilt
SEO skoor
71.23%
104
Tulemus saavutatud
146
Maksimaalne punktisumma
Peamine teave
ℹ️
Pealkiri: Synapse - Global Drug Intelligence Database
Kirjeldus: Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global pharmaceutical innovation.
Märksõnad: Synapse, Drug Intelligence, Database
Lehekülje kodeering:utf-8
Lehekülje faili suurus: 176 KB
Serveriteave
🖥️
IP: 18.204.189.23
Asukoht: United States,US,Ashburn,20149,39.0469,-77.4903,America/New_York
HTTP-server: nginx
Kodeerimine: utf-8
Toiteallikaks: nuxt
Meta siltide loend
🏷️
charset: utf-8
name: description content: Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global pharmaceutical innovation.
name: keywords content: Synapse, Drug Intelligence, Database
property: og:title content: Synapse - Global Drug Intelligence Database
property: og:description content: Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global pharmaceutical innovation.
name: twitter:title content: Synapse - Global Drug Intelligence Database
name: twitter:description content: Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global pharmaceutical innovation.
HTML-i ja päiste vaheline märgikodeering on ühtlane.
✓
Lehekülje suurus
180571 bytes
Lehekülje suurus kiireks laadimiseks vastuvõetav.
!
Vahendid
193 total
Liiga palju ressursse. Parema jõudluse saavutamiseks optimeerige ja kombineerige faile.
✓
Hreflangi sildid
0 hreflang tags
Kui teil on mitmekeelne sisu, lisage hreflang-sildid.
✓
Robots.txt
Exists
Leiti fail Robots.txt.
✓
Sitemap
Declared in robots.txt
Saidikaart on deklareeritud failis robots.txt.
✓
HTTPS
Yes
Turvaline HTTPS-ühendus on lubatud.
✓
Kokkusurumine
gzip
Kiiremaks laadimiseks on lubatud Gzip- või Zstd-tihendamine.
!
Vahemällu salvestamine
Not set
Lisage vahemälu juhtimise päised, et parandada korduvate külastajate laadimiskiirust.
✓
Lehekülje kiirus
8.02 ms
Suurepärane laadimiskiirus.
On-Page SEO
✓
Pealkiri
Synapse - Global Drug Intelligence Database
Hea pealkirja pikkus (30-60 tähemärki).
!
Meta kirjeldus
Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global pharmaceutical innovation. Lenght:324
Meta kirjeldus on liiga pikk. Vähendage 100–160 tähemärgini.
!
H1 Pealkiri
0 found - ""
Lisage täpselt üks peamiste märksõnadega H1 pealkiri.
✓
Sõnade arv
810
Hea sisu pikkus (soovitatav on 500-2000 sõna).
!
Kanooniline silt
Lisage kanooniline silt, et vältida dubleeriva sisuga probleeme.
✓
Dubleeri meta
[]
Dubleerivaid metasilte ei leitud.
✓
Märksõnad
Synapse, Drug Intelligence, Database
Meta märksõnade komplekt (märkus: suuremad otsingumootorid ei kasuta).
Vaateava metasilt on mobiilseadmete jaoks õigesti seadistatud.
✓
Ava graafik
All OG tags present.
Kõik olulised OpenGraphi sildid on olemas.
!
Struktureeritud andmed
0 JSON-LD scripts
Rikkalike väljavõtete ja parema SEO jaoks lisage struktureeritud andmed (JSON-LD).
Positsioonid sisse Google
Otsi fraase - Google
🔍
positsioon
Fraas
Lehekülg
Katkend
3
/drug/931127bd1bd445...
BXY-4 , Initially developed by Nanjing Baixinyu Pharmaceutical Co., Ltd., Now, its global highest R&D status is Preclinical, Active Org.: Nanjing Baixinyu ...
5
/drug/46fdb9efe1c649...
Our results suggest that Ky2 may be a potential chemopreventive and chemotherapeutic agent by modulating Sp1 in human breast cancer cells.
6
/organization/b7f6c7...
Explore Medisrael Ltd . with its drug pipeline, therapeutic area, technology platform, .
15
/drug/b9b3433e54614c...
Pro-101-1 : a PDGFR agonists Drug, Initially developed by B&K Corporation Limited., Now, its global highest R&D status is Phase 2, Mechanism: PDGFR ...
24
/article/what-is-tes...
16 июн. 2024 г. — In conclusion, Testosterone Enanthate is a potent androgen used in treating low testosterone levels and enhancing physical performance. While ...
27
/drug/7aab4ce7a13347...
SC-101: a nectin-4 modulators Drug , Initially developed by Tianjin Conjustar Biotechnology Co., Ltd., Now, its global highest R&D status is Phase 2, ...
34
/drug/b1bf28d200ca42...
Lu-177- DGUL : a PSMA modulators Drug, Initially developed by Cellbion Co., Ltd., Now, its global highest R&D status is Phase 1/2, Mechanism: PSMA ...
37
/article/what-are-no...
25 июн. 2024 г. — NOD2 modulators are substances that can either enhance or inhibit the activity of the NOD2 receptor . They work by influencing the receptor's ...
Lisateenused
💎
×
✓
Платеж успешен!
Спасибо за ваш заказ. Мы свяжемся с вами в ближайшее время.
×
Makse
×
Авторизоваться
Зарегистрироваться
Войти в аккаунт
Или войдите через Telegram
Зарегистрироваться через Telegram
Как это работает:
Введите имя и email выше
Нажмите кнопку для открытия Telegram
Завершите регистрацию в боте (потребуется номер телефона)
Получите email с данными для входа
×
🔐
Код подтверждения
Код был отправлен в Telegram. Введите его ниже:
Код действителен: 05:00
×
📱
Завершите регистрацию в Telegram
Telegram был открыт в новой вкладке.
Если бот не открылся автоматически, используйте кнопку ниже или отсканируйте QR-код.
Отсканируйте QR-код для открытия бота
Ожидание подтверждения... 05:00
Как это работает:
1. Нажмите "Открыть Telegram" или отсканируйте QR-код
2. В боте нажмите START и поделитесь номером телефона
3. Статус подтверждения обновится автоматически